Research in allergic diseases diagnosis and treatment

SCIENTIFIC PRODUCTION PRIOR TO DECEMBER 2019 IS LINKED TO THE GROUP "EPIDEMIOLOGY AND CLINICAL BIOSTATISTICS"

Milestones

  1. Obtaining funding for the food allergy research line. 1) "Effect of the 'milk ladder' intervention on the development of tolerance and recognition of B-cell epitopes in children allergic to cow's milk proteins" (ISCIII-PI16 / 00205). 2) "Validation and implantation of a tool to predict the efficacy and safety of the treatment of allergy to cow's milk proteins by oral immunotherapy" (ISCIII-DTS16 / 00131). Obtención de financiación para la línea de investigación de alergia a los alimentos. 
     
  2. Obtaining funding for the research line Diagnosis and treatment of allergy to chemotherapy drugs. 1) "Hypersensitivity to Platins and Taxanes: description of immunological phenotypes and search for biomarkers that optimize diagnosis and treatment” (ISCIII - PI18 / 00962). 2) "Hypersensitivity to Platins and Taxanes: description of immunological phenotypes and search for biomarkers that optimize diagnosis and treatment" (Fundación 2000. Merck grant 2019).
     
  3. Obtaining funding for the Anaphylaxis and mastocytosis research line: "Evaluation of mast cell activation in acute coronary syndrome" (SEAIC Foundation 2018) and intramural IRYCIS grant 2018.
     
  4. Publication of a systematic review on the usefulness of identifying allergenic protein peptides in the diagnosis and treatment of food allergy. Sánchez-Ruano L, de la Hoz B, Martínez-Botas J. Clinical utility of microarray B-cell epitope mapping in food allergies: A systematic review. Pediatr Allergy Immunol. 2020; 31 (2): 175-185. PMID: 31655013.
     
  5. Public-private partnership with an Spanish pharmaceutical company for the treatment and diagnosis of allergic diseases. Partners:  private company, the IRYCIS Allergy Dpt. and the Microarray Unit. Goal: development of patent P201331200 - "Set of peptides", for monitoring milk immunotherapy in allergic patients. 2015”

Networks and alliances